- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04363528
Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU (COVIDOP-DVT)
July 25, 2022 updated by: Aurelien Maurizot, Versailles Hospital
Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU.
This is a monocentric interventional study (RIPH 2).
Study Overview
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Le Chesnay, France, 78150
- Centre Hospitalier de Versailles
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient > or =18 years
- Hospitalization in intensive care
- PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs
Exclusion Criteria:
- Pregnancy in progress
- Patient <18 years
- Patients deprived of freedoms or under guardianship
- Patient or family opponent of protocol participation
- patient on curative anticoagulant for more than 48H00
- impossible Venous Doppler Echo
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Doppler Echo
patients will have a Doppler Echo when they enter ICU (within 48 hours) and a second Doppler Echo 7 days later
|
2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
Time Frame: Day 0
|
Deep vein thrombosis at Doppler echo
|
Day 0
|
Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
Time Frame: Day 7
|
Deep vein thrombosis at Doppler echo
|
Day 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 24, 2020
Primary Completion (ACTUAL)
December 24, 2020
Study Completion (ACTUAL)
June 24, 2021
Study Registration Dates
First Submitted
April 23, 2020
First Submitted That Met QC Criteria
April 24, 2020
First Posted (ACTUAL)
April 27, 2020
Study Record Updates
Last Update Posted (ACTUAL)
July 26, 2022
Last Update Submitted That Met QC Criteria
July 25, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P20/08_COVIDOP-DVT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Vein Thrombosis
-
University of OklahomaPfizerCompleted
-
University Medical Center GroningenCompletedSuspected Upper Extremity Deep Vein ThrombosisAustria, Netherlands, Italy, Belgium, Switzerland, Germany, United States
-
National Taiwan University HospitalUnknownUpper Extremity Deep Vein Thrombosis, SecondaryTaiwan
-
University of Missouri-ColumbiaTerminatedDEEP VEIN THROMBOSISUnited States
-
Vetex Medical Ltd.CompletedDeep Vein Thrombosis LegIreland, Germany, Bulgaria, United Kingdom
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedSuspected Deep Vein ThrombosisCanada
-
Diakron PharmaceuticalsCompleted
-
UPECLIN HC FM Botucatu UnespCompletedProphylaxis of Deep Vein ThrombosisBrazil
-
MinaPharm PharmaceuticalsRecruitingProphylaxis of Deep Vein ThrombosisEgypt
-
University of Kansas Medical CenterPenumbra Inc.CompletedAcute Deep Vein ThrombosisUnited States
Clinical Trials on Doppler Echo
-
Ramsay Générale de SantéHôpital Privé Jacques Cartier, service réanimation Dr BougouinUnknownPneumonia, Viral | Embolism and Thrombosis | COVIDFrance
-
University Hospital, Strasbourg, FranceActive, not recruitingLymphedema | Turner Syndrome | Peripheral Angiopathy | Vascular MalformationFrance
-
Groupe Hospitalier Paris Saint JosephWithdrawn
-
University Hospital, Strasbourg, FranceTerminatedHypertension | Chronic PeriodontitisFrance
-
Centre Hospitalier de VichyActive, not recruitingArteriovenous Fistula StenosisFrance
-
Rennes University HospitalCompletedDoppler EchocardiographyFrance
-
Assiut UniversityNot yet recruitingRight Ventricular Function
-
Centre Hospitalier Intercommunal de Toulon La Seyne...CompletedCarotid StenosisFrance
-
Hospital de Clinicas de Porto AlegreCompletedDeep Venous Thromboses | Deep Venous Thrombosis of Left Leg | Deep Venous Thrombosis of Right Leg | Deep Venous Thrombosis Proximal
-
Maxima Medical CenterNot yet recruitingIliac Artery Occlusion | Iliac Artery Disease | Iliac Artery Stenosis | Near-Infrared Spectroscopy